Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2023

Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET

Résumé

Medullary thyroid carcinoma (MTC) is a rare neoplasm supported by a strong genetic determinism. This review summarizes the genetic landscape of MTC at both germline and somatic levels to understand the molecular basis and the natural history of the tumour, mainly but not exclusively, linked to RET proto-oncogene genetic abnormalities. RET is a tyrosine kinase receptor that represents a therapeutic target with encouraging results. However, some RET genetic variations could lead to treatment resistance.
Fichier principal
Vignette du fichier
cancers-15-04865.pdf (1.96 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04231638 , version 1 (06-10-2023)

Licence

Identifiants

Citer

Nicolas Sahakian, Frédéric Castinetti, Pauline Romanet. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET. Cancers, 2023, ⟨10.3390/cancers15194865⟩. ⟨hal-04231638⟩
14 Consultations
15 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More